24 January 2019
This Overview has been created by the Life Sciences Asia Pacific Network, of which Corrs is a member. It contains Australia-specific content by Eugenia Kolivos (Partner), Isaac Lin (Special Counsel) & Heather Curd (Senior Associate).
For many years, emerging markets have been strategically important for the growth and development of the Lifesciences sector. Almost 90% of the sector now operates in an emerging market, including the Asia-Pacific region.
The Life Sciences Asia Pacific Network has prepared this guide, which gives a comparative overview of the distribution and marketing of drugs in Australia, China, India, Indonesia, Japan, Korea, Singapore, Taiwan, Thailand and Vietnam. It also highlights the key legal and commercial issues to consider when doing business in the region.
To access a PDF copy of A Comparative overview of Distribution and Marketing of Drugs across Asia-Pacific, click the 'Download PDF' button to the right.
A Comparative overview of Distribution and Marketing of Drugs across Asia-Pacific (Overview), is a publication of the Life Sciences Asia Pacific Network. The Overview is published by CMS, and reproduced with its permission.
The Overview provides information and comments on legal issues and developments of interest to our clients and friends. It is not a comprehensive treatment of the subject matter covered and is not intended to provide legal advice. Readers should seek legal advice before taking any action with respect to the matters discussed in the Overview.
The content of this publication is for reference purposes only. It is current at the date of publication. This content does not constitute legal advice and should not be relied upon as such. Legal advice about your specific circumstances should always be obtained before taking any action based on this publication.